A high affinity human antibody antagonist of P-selectin mediated rolling.

We have characterized the IgG form of a previously isolated and engineered single-chain Fv (scFv), named RR2r3s4-1, that binds to human PSGL-1. This fully human IgG was determined to have a Kd of 1.8+/-0.7 nM by fluorescence quenching titration. It better inhibits P-selectin-PSGL-1 interactions than a commercially available murine monoclonal antibody KPL1 and better inhibits neutrophil rolling than KPL1. Thus, RR2r3s4-1 is the most effective antibody at inhibiting P-selectin-PSGL-1 interactions known. Specificity analysis reveals that RR2r3s4-1 does not cross react with murine PSGL-1 and thus requires more than tyrosine sulfate for binding to human PSGL-1. This evidence demonstrates the therapeutic potential of this antibody as a potent anti-inflammatory therapeutic.

[1]  K E Norman,et al.  Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. , 1995, Blood.

[2]  H. Steven Wiley,et al.  Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library , 2003, Nature Biotechnology.

[3]  K. Ley,et al.  The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. , 1997, Blood.

[4]  W. Somers,et al.  Insights into the Molecular Basis of Leukocyte Tethering and Rolling Revealed by Structures of P- and E-Selectin Bound to SLeX and PSGL-1 , 2000, Cell.

[5]  A. Varki.  Selectin ligands: will the real ones please stand up? , 1997, The Journal of clinical investigation.

[6]  R. Cummings,et al.  Visualization of P-selectin Glycoprotein Ligand-1 as a Highly Extended Molecule and Mapping of Protein Epitopes for Monoclonal Antibodies (*) , 1996, The Journal of Biological Chemistry.

[7]  R. Alon,et al.  An Activated L-selectin Mutant with Conserved Equilibrium Binding Properties but Enhanced Ligand Recognition under Shear Flow* , 2000, The Journal of Biological Chemistry.

[8]  A. Hafezi-Moghadam,et al.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.

[9]  G S Kansas,et al.  Selectins and their ligands: current concepts and controversies. , 1996, Blood.

[10]  A. M. Lefer,et al.  Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. , 1999, Cardiovascular research.

[11]  S. Benkovic,et al.  Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase. , 1988, Journal of medicinal chemistry.

[12]  D. J. Goetz,et al.  The N-terminal peptide of PSGL-1 can mediate adhesion to trauma-activated endothelium via P-selectin in vivo. , 2002, Blood.

[13]  B. Furie,et al.  The Biology of P-Selectin Glycoprotein Ligand-1: Its Role as a Selectin Counterreceptor in Leukocyte-Endothelial and Leukocyte-Platelet Interaction , 1999, Thrombosis and Haemostasis.

[14]  T. Springer,et al.  The faster kinetics of L-selectin than of E-selectin and P-selectin rolling at comparable binding strength. , 1997, Journal of immunology.

[15]  R. Schaub,et al.  Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. , 1999, Circulation.

[16]  Pei-shan Wu,et al.  Biochemical and Biophysical Research Communications , 1960, Nature.

[17]  Richard D. Cummings,et al.  Affinity and Kinetic Analysis of P-selectin Binding to P-selectin Glycoprotein Ligand-1* , 1998, The Journal of Biological Chemistry.

[18]  R. Warnke,et al.  A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin. , 1998, Blood.

[19]  A. M. Lefer,et al.  Essential Role of P-Selectin in the Initiation of the Inflammatory Response Induced by Hemorrhage and Reinfusion , 1999, The Journal of experimental medicine.